On Thursday, spring will blossom into our lives again, but I’ve already noticed the first true harbinger of the season — kids riding bikes with joyful abandon.

Bicycle's immuno-oncology pipeline is headed by BT7480, a tumour-targeted immune cell agonist (TICA) that binds to Nectin-4 on cancer cells and stimulates CD137 on immune cells, driving an immune ...